Alltranz Inc.
Records under this name other than patents Alltranz Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,511,054 | Transdermally Deliverable Opioid Prodrugs, Abuse-Resistant Compositions and Methods of Using Opioid Prodrugs Formerly held In force · High confidence | In force | High confidence | |
| US 8,309,568 | Transdermally Deliverable Opioid Prodrugs, Abuse-Resistant Compositions and Methods of Using Opioid Prodrugs Formerly held In force · High confidence | In force | High confidence | |
| US 9,695,143 | Prodrugs of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same Formerly held In force · High confidence | In force | High confidence | |
| US 9,957,246 | Prodrugs of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same Formerly held In force · High confidence | In force | High confidence | |
| US 8,980,942 | Prodrugs of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same Formerly held In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 8,293,786 | Prodrugs of Cannabidiol, Compositions Comprising Prodrugs of Cannabidiol and Methods of Using the Same Formerly held In force · High confidence | In force | High confidence | |
| US 8,227,627 | Prodrugs of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same Formerly held In force · High confidence | In force | High confidence | |
| US 8,449,908 | Transdermal Delivery of Cannabidiol Formerly held Term ended Term ended Mar 16, 2026 · Medium confidence | Term ended | Term ended Mar 16, 2026 | Medium confidence |
| US 8,481,560 | Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists Formerly held Lapsed on the fee record Ended Jul 9, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jul 9, 2025 | From the USPTO record |
| US 8,435,556 | Transdermal Delivery of Cannabidiol Term ended Term ended Jun 24, 2023 · Medium confidence | Term ended | Term ended Jun 24, 2023 | Medium confidence |